Widening losses and going concern language suggest rising risk of equity dilution or debt restructuring. Monitor cash runway (current $19.2M at ~$1.4M/quarter operating burn gives ~3.6 quarters) and any capital raise announcements.
Price Chart
Executive Summary
BioHarvest Sciences reported Q1 2026 revenue of $8.5M (+8.2% YoY) but net loss widened to $2.6M from $2.3M, with operating loss increasing and cash burn of $3.8M. The MD&A includes a going concern warning citing substantial doubt about the company's ability to continue, despite $19.2M cash on hand. A CEO transition (Chairman Rakib replacing Sobel) was announced post-quarter.
Key Facts
- Q1 2026 revenue $8,507k vs $7,860k YoY (+8.2%)
- Net loss widened to $2,641k from $2,338k YoY
- Operating loss increased to $1,834k from $1,719k
- Cash and equivalents fell to $19,167k from $23,025k at Dec 2025, net cash burn of $3,812k
- Going concern warning: 'substantial doubt about the Company's ability to continue'
- CEO transition: Chairman Zaki Rakib assumed CEO role, former CEO Ilan Sobel moved to Board
- Gross margin improved to 59% from 58%
- Weighted average shares outstanding 22.7M vs 17.3M YoY (dilution)
Financial Impact
Revenue grew modestly (+$647k) but operating loss grew by $115k and net loss by $303k; cash position declined 17% in one quarter
Risk Factors
- Going concern risk with substantial doubt disclosure
- Continued operating losses and cash burn
- Potential future dilutive financing
- Geopolitical risk from Israel operations (Middle East conflict)
- Limited liquidity runway for growth investments
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001723464-26-000028 |
| Document: bhsc_ex992.htm | 0001723464-26-000028 |
| Document: bhsc_6k.htm | 0001723464-26-000028 |
| Document: bhsc_ex994.htm | 0001723464-26-000028 |
| Document: bhsc_ex993.htm | 0001723464-26-000028 |
| Document: 0001723464-26-000028-index-headers.html | 0001723464-26-000028 |
| Document: 0001723464-26-000028-index.html | 0001723464-26-000028 |
| Document: 0001723464-26-000028.txt | 0001723464-26-000028 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.75 $1.67 | ▼ −4.18% | ▼ −4.64% | $1.68 (−3.72%) |
Oct 8, 2026 18d ago | 6-K | $1.50 $1.70 | ▲ +13.71% | ▲ +13.99% | $1.68 (+12.37%) |
Sep 15, 2026 5w ago | 6-K | $1.66 $1.46 | ▼ −12.05% | ▼ −14.61% | $1.68 (+1.20%) |
Sep 14, 2026 6w ago | 6-K | $1.78 $1.51 | ▼ −14.93% | ▼ −17.04% | $1.68 (−5.35%) |
Jul 15, 2026 14w ago | 6-K | $2.85 $2.18 | ▼ −23.51% | ▼ −22.53% | $1.68 (−41.05%) |
Jun 18, 2026 18w ago | 6-K | $3.26 $2.75 | ▼ −15.64% | ▼ −13.98% | $1.68 (−48.47%) |
May 28, 2026 21w ago | 6-K | $3.90 $3.56 | ▼ −8.72% | ▼ −8.67% | $1.68 (−56.92%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▼ −8.17% | ▼ −7.46% | $1.68 (−59.62%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▲ +8.17% | ▲ +7.46% | $1.68 (+59.62%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▼ −8.17% | ▼ −7.46% | $1.68 (−59.62%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers